What is the Impact Factor of Revista Espanola De Quimioterapia?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Revista Espanola De Quimioterapia is 2.80, ranking in quartile Q3 of Web of Science (SCIE).

Is Revista Espanola De Quimioterapia indexed in Web of Science or Scopus?

Yes, Revista Espanola De Quimioterapia is indexed in Web of Science (SCIE, Q3 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.611 (Q2) and an H-index of 37.

Who publishes Revista Espanola De Quimioterapia and what is the Article Processing Charge (APC)?

Revista Espanola De Quimioterapia is published by Sociedad Espanola de Quiminoterapia. It operates under a Diamond Open Access model, exempting authors completely from Article Processing Charges ($0 USD APC).

What is the ISO-4 abbreviation and acronym of Revista Espanola De Quimioterapia?

The official ISO-4 abbreviation of Revista Espanola De Quimioterapia is "REV ESP QUIM" with common acronym "revespquimioter". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q3Scopus Q2SCImago #9,649Diamond OAHybrid

Revista Espanola De Quimioterapia

Acronym:revespquimioter

•

Abbreviation (ISO):REV ESP QUIM

•

Identifier (ISSN):0214-3429(Print)

•

Publisher:Sociedad Espanola de Quiminoterapia

Official Website Submission Portal Compare

Clarivate IF (2026)

2.8↑ +0.6

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Revista Espanola De Quimioterapia

WoS Q3

Annual Impact Factor Metric

Current (2026):2.8

Scopus SJR & RankScopus Q2

0.611

#9,649

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

37 papers with at least that number of citations each

WoS: SCIE / JCRQ3

Self-Citation Rate10.5%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

93articles/year

99.41% Gold OA•81.9% Original Research

Aims & Scope

The official journal of the Sociedad Española de Quimioterapia (Spanish Society of Chemotherapy), publishes articles that further knowledge and advance the science and application of antimicrobial chemotherapy with antibiotics and antifungal, antiviral and antiprotozoal agents primarily in human medicine. Authors sign an exclusive license agreement, where authors have copyright but license exclusive rights in their article to the Publisher. All manuscripts are free open access. Revista Española de Quimioterapia includes the following sections: reviews, original articles, brierf reports, letters, and consensus documents.

Topics Covered (Recognized by AI)

BiologyMedicineGeneticsMicrobiologyChemistryInternal MedicineBiochemistryGeologyPaleontologyBacteriologyPathologyImmunologySurgeryIntensive Care MedicineOrganic ChemistryVirology

Primary Research Areas

Medicine Pharmacy

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

MICROBIOLOGY

Rank105/167

IndexSCIE

JCRSCIE2026

PHARMACOLOGY & PHARMACY

Rank181/356

IndexSCIE

JCISCIE2026

MICROBIOLOGY

Rank133/167

IndexSCIE

JCISCIE2026

PHARMACOLOGY & PHARMACY

Rank248/356

IndexSCIE

Category	Index	Rank	Quartile
MICROBIOLOGY	JCRSCIE	105/167	Q3
PHARMACOLOGY & PHARMACY	JCRSCIE	181/356	Q3
MICROBIOLOGY	JCISCIE	133/167	Q4
PHARMACOLOGY & PHARMACY	JCISCIE	248/356	Q3

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

11 year

2026Latest

IF2.8

Articles / Year50

Total Citations4

2025

IF2.2

Articles / Year81

Total Citations57

2024

IF1.9

Articles / Year82

Total Citations245

2023

IF1.9

Articles / Year127

Total Citations585

2022

IF2.515

Articles / Year155

Total Citations1,227

Year	Impact Factor	Articles / Year	Total Citations
2026	2.8	50	4
2025	2.2	81	57
2024	1.9	82	245
2023	1.9	127	585
2022	2.515	155	1,227
2021	1.553	144	1,153
2020	1.132	94	684
2019	0.76	1	49
2018	0.605	—	—
2012	—	1	0
2000	—	1	4

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #9,649Scopus Q2Diamond OASCImago Profile

Scopus Coverage:1989-2025

•

Scopus Broad Areas:MedicinePharmacology, Toxicology and Pharmaceutics

Scopus Citation Rank (SJR)Q2

0.611

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2

Citations / Doc (2 years)

1.76

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

100% Free

Diamond Open Access: Authors publish completely free of charge with zero author-facing fees.

Diamond Open Access

Scopus 3-Year Publication & Citation Window

3-Year Citations622

3-Year Documents350

Citable Documents225

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)1

Citations in government and international policy documents

Female Author Rate52.0%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Medicine (miscellaneous)Q2

Microbiology (medical)Q2

PharmacologyQ3

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 10.5%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

4区 (Zone 4)Medicine

Minor Category (Specific Field):

4区MICROBIOLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Revista Espanola De Quimioterapia (acronym: revespquimioter, abbr: REV ESP QUIM, ISSN: 0214-3429) is a peer-reviewed international scholarly journal in the field of Medicine, published by Sociedad Espanola de Quiminoterapia in Spain since 1988. The periodical holds a Journal Impact Factor (JIF) of 2.80, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.611 (Q2), an H-index of 37.

The journal enforces rigorous peer evaluation with a publication frequency of Quarterly, an annual output of approximately 93 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with Diamond Open Access (100% free of author APC charges). It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.